Literature DB >> 12210875

Sleep disorders in Parkinson's disease.

Suresh Kumar1, Manvir Bhatia, Madhuri Behari.   

Abstract

We sought to estimate the frequency and nature of sleep disturbances in Indian Parkinson's disease (PD) patients. One hundred forty nine consecutive PD patients attending the Movement Disorders Clinic of the All India Institute of Medical Sciences, New Delhi, India and 115 age-matched healthy controls participated. After clinical evaluation, sleep assessment was done using a 23-question, validated sleep questionnaire. Mean age of PD patients and the duration of illness were 58.37 (S.D. 10.45) years and 5.7 (S.D. 3.85) years, respectively. The mean age of the controls was 56.50 (S.D. 11.45) years (P > 0.05). Sleep problems were seen in 63 (42%) PD patients compared to 12% of controls. These were: insomnia in 32%, nightmares in 32%, and excessive day time sleepiness in 15% of PD patients as compared with 5%, 5% and 6%, respectively, in controls (P < 0.025). Presence of nightmares was significantly associated with higher Hoehn and Yahr score (P < 0.002), high unified Parkinson's disease rating scale (UPDRS) Part I score (P < 0.000) and levodopa dose (P < 0.025). Excessive daytime sleepiness correlated with higher Hoehn and Yahr stage (P < 0.004), and levodopa dose (P < 0.040). The sleep latency was longer in PD patients as compared to controls (P < 0.000). Multiple logistic regression analysis showed association of sleep disturbances with UPDRS Part III, Schwab and England score, levodopa dose, rigidity score, and bradykinesia score. Sleep problems are much more common in PD patients compared to controls (P < 0.001), and correlate with increased severity of disease. Copyright 2002 Movement Disorder Society

Entities:  

Mesh:

Year:  2002        PMID: 12210875     DOI: 10.1002/mds.10167

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  53 in total

1.  Sleep disorders and daytime sleepiness in Parkinson's disease.

Authors:  Renee Monderer; Michael Thorpy
Journal:  Curr Neurol Neurosci Rep       Date:  2009-03       Impact factor: 5.081

2.  Learning and consolidation of visuo-motor adaptation in Parkinson's disease.

Authors:  Lucio Marinelli; Domenica Crupi; Alessandro Di Rocco; Marco Bove; David Eidelberg; Giovanni Abbruzzese; M Felice Ghilardi
Journal:  Parkinsonism Relat Disord       Date:  2008-04-18       Impact factor: 4.891

3.  Treatment options for sleep dysfunction in Parkinson's disease.

Authors:  Mary Ann Thenganatt; Steven J Frucht
Journal:  Curr Treat Options Neurol       Date:  2011-10       Impact factor: 3.598

Review 4.  Circadian and sleep disorders in Parkinson's disease.

Authors:  Aleksandar Videnovic; Diego Golombek
Journal:  Exp Neurol       Date:  2012-08-23       Impact factor: 5.330

5.  Sleepiness and Unintended Sleep in Parkinson's Disease.

Authors:  David B. Rye
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

6.  Impact of limiting visual input on gait: Individuals with Parkinson disease, age-matched controls, and healthy young participants.

Authors:  Laura M Pilgram; Gammon M Earhart; Kristen A Pickett
Journal:  Somatosens Mot Res       Date:  2016-03-18       Impact factor: 1.111

7.  A long-term prospective follow-up study of incident RLS in the course of chronic DAergic therapy in newly diagnosed untreated patients with Parkinson's disease.

Authors:  Stefano Calzetti; Monica Angelini; Anna Negrotti; Elena Marchesi; Matteo Goldoni
Journal:  J Neural Transm (Vienna)       Date:  2013-12-20       Impact factor: 3.575

Review 8.  Sleep as a Therapeutic Target in the Aging Brain.

Authors:  Thierno M Bah; James Goodman; Jeffrey J Iliff
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

9.  Identifying sleep disturbances in Huntington's disease using a simple disease-focused questionnaire.

Authors:  Anna O G Goodman; A Jennifer Morton; Roger A Barker
Journal:  PLoS Curr       Date:  2010-10-15

10.  Absence of co-morbidity of Parkinson disease and restless legs syndrome: a case-control study in patients attending a movement disorders clinic.

Authors:  Stefano Calzetti; Anna Negrotti; Giuseppe Bonavina; Monica Angelini; Elena Marchesi
Journal:  Neurol Sci       Date:  2009-03-10       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.